Our class III product lines are successfully submitted to CFDA for Innovative Medical Devices green channel approval
In order to encourage innovation and promote the application of new technologies, China regulatory authorities set up special approval channels for innovative medical devices to ensure the safety and efficacy of medical products. For innovative medical devices that have been examined and approved by special procedures, priority should be given, and communication with applicants should be strengthened. The prioritize process via green channel will greatly benefit innovative medical device manufacturer to obtain CFDA approval.
February 05, 2019
Tiger Lifescience sets up Guangzhou office
To rapidly develop business in China, we set up a new office in Guangzhou to leverage resource from China Bay area incl. Guangdong, Hong Kong and Macau and expand our business in Southeast Asia.
November 05, 2018
Professional Education Program in China Leading Hospitals
Tiger Lifescience conducted “Hospital Acquired Infection Prevention Solution” Prof Ed training in China leading hospitals：Peking Union Medical College Hospital（Beijing Xiehe Hospital) and People's Liberation Army General Hospital (301 Hospital)
Tiger Lifescience conducted training seminar for ICU doctors and nurses in China 301 hospital on pathophysiology of catheter-related infection and on how to prevent and control CRBSI. Also, We shared what US Medicare did in HAC reduction program and what is the guidelines for the prevention of Catheter-Related infections in adult and pediatric patients.
October 16, 2018
Tiger Lifescience won the First Prize of healthcare industry in the Third Shanghai FTZ Overseas Talents Innovation Conference
Tiger Lifescience stood out from 76 teams that came from 22 countries and won the Frist Prize of healthcare industry and highest investment potential award in the Third Shanghai FTZ Overseas. Afterward, Tiger Lifescience attracted attention from Shanghai multiple governmental districts and cross-border investors as well.
August 07, 2017
Our product lines are successfully FDA listed
Three product lines are successfully listed in FDA including CRBSI preventive devices for adults and children, umbilicus catheter protector for infants, wound care products for minimal invasive surgeries both for adults and children, neonatal umbilicus protector, etc.
Most of our devices are class I devices and 510K exempted.
January 31, 2017
US patent granted on Jan 31, 2017
Cheers for receiving the certificate of grant from USPTO on Jan 31 2017!
January 23, 2017
Initial Closing of the 2nd Angel Round
Tiger Lifescience is glad to announce the initial closing of the 2nd Angel round with our strategic investor, Entropy Capital on Jan 23rd, 2017.
December 21, 2016
European Patent Granted
We are glad to receive the certificate of grant of our newly applied patent from European patent office on Dec 21, 2016, which will ensure us to expand our world wide market in the EU area.
October 01, 2016
Tiger Lifescience moves to the new office in Mountain View, California
We are excited to move!
Our new office is at TechCode Accelerator in Silicon Valley. The Accelerator supports startups with incubation, acceleration, venture funding, and strategic consultation. We are happy to be in the leading global entrepreneurial ecosystem here. Our address is: 1172 Castro St, Mountain View, CA, 94040.
Tiger Lifescience receives Intention to Grant letter from European Patent Office
European Patent office issued patent intention to grant for our new patent on Sep 6th, 2016.
July 11, 2016
USPTO issues Notice of Allowance for our new patent application
Jul 11th, 2016, we are pleased to receive the Notice of Allowance from USPTO for our new patent.
June 10, 2016
Tiger Lifescience closes series A angel funding
Tiger Lifescience Inc. receives series A angel funding from TEEC Angel Fund (TAF). TAF is a Silicon Valley based super angel fund operated by a team of veteran entrepreneurs or executives with deep investment experience. We believe by leveraging the strong healthcare industry resources of TAF, Tiger Lifescience Inc. will grow faster and healthier.
July 29, 2016
Tiger Lifescience sets up its China Office in Jiaxing, Zhejiang, China
To grab the fast developing trend of emerging market in Asia Pacific, especially in China, and to meet the high demand of preventing Hospital Acquired Infection in China, we decided to go to China market. Our new office is in Shanghai Jiaotong University high-tech park in Jiaxing city, Zhejiang, the most innovative and entrepreneurial area in China. The local government is very supportive by providing preferential measures.
We are very pleased to join TechCode AI+ accelerator program that focuses resources and connections specifically to startups in the AI spaces who already have a prototype. The goal of the program is to speed up commercialization for startups by introducing partners and investors to startups, while helping startups test global market entry and fine tune or add artificial intelligence elements to their product.
April 27, 2016
UCAHP China Trip
We took part in the China trip organized by UCAHP (US-China Association of High-level Professionals) during Apr 20-27. In this trip we visited several high tech parks and incubators in Suzhou, Shanghai, Jiashan, Hangzhou, and Nanjing, took part in the Nanjing Overseas Scholars Exchange Conference attended by more than 3200 Chinese overseas scholars all over the world and learned more about the endeavor of Chinese government to attract worldwide talents and technologies to China. We also met with startups and established enterprises in China and discussed the market penetration and cooperation opportunities.
We took part in the May Flower trip to China organized by TechCode during Apr 11-15 together with the founders of nine silicon valley startups. The purpose of this trip is mainly to know more about the China policies entrepreneurial environments regarding healthcare industry and high-tech industry in Beijing and adjacent areas. We visited the TechCode headquarter in Beijing Zhongguancun and several industrial parks in Gu'An, Xianghe and Dachang District, around Beijing city in Hebei province. Each industrial park is a new town and focuses in different industries. We also pitched our projects to the Chinese investors and received much attention.
Tiger Lifescience took part in MDM West 2016, Anaheim
We took part in the MDM West 2016 in Anaheim, CA from Feb 8th to Feb 12th. The MDM West is the largest expo of medical design and manufacturing in west coast. We explored the event and found some potential contract manufacturers in the medical industry.
We are pleased to receive the Certificate of Grant of Standard Patent from the Australia Patents Office on Jan 6th, 2016.
January 16, 2016
Innovation Jiaxing . Elite Leader. Class A Award granted to Tiger Lifescience
Tiger Lifescience won the class A prize from Jiaxing, China government as Leader for Innovation and Entrepreneurship in the project of "Innovation Jiaxing, Elite Leaders". The project is sponsored by Chinese government to foster innovation and entrepreneurship and attract overseas scholars to go back China. Our Project, Disruptive CRBSI (Catheter Related Blood Stream Infection) Prevention and Control Device won the 1st Prize (Class A award) in thousands of projects. This award will greatly facilitate our expansion to China market.
September 29, 2015
Tiger Lifescience won the 2nd Prize in the 5th US-China Health Summit and took part in the 1st Young Leadership Forum in Health at Harvard University, Boston
We took part in the 1st Young Leadership Forum in Health in Harvard University and introduced our innovative project of CRBSI prevention and control to resolve the unmet clinical needs of catheter related infection. Our project won the 2nd prize in the Youth Startup Contest of US-China Healthcare Summit one month ago in Beijing.
Tiger Lifescience won the Excellent Award in DemoHealth Innovation Competition
Tiger Lifescience won the Excellent Award at the DemoHealth Innovation Competition in Beijing, China. DemoHealth is a Healthcare industry-specialized group comprising the most innovative companies, renowned venture capitalists, government officials from CFDA and High-tech Parks, etc. The series of DemoHealth innovation and entrepreneurship competitions represents the trend of healthcare industry in China.
Tiger Lifescience won the 2nd Prize in US-China Summit Contest China Final, Beijing
Tiger Lifescience won the 2nd Prize in the US-China Health Summit Contest China Final in Beijing. The 15 teams selected from more than 200 projects competed for 3 awards for the 1st Young Leadership Forum in Health to be held in US-China Health Summit next month in Harvard University, Boston.
We are delighted to receive grant certificate of our new patent from Japanese patent office on Jul 30th！
June 18, 2015
Meet with Dr.James M Anderson in Case Western University
We met with Dr. James M. Anderson in Cleveland Medical Center this morning and discussed our potential cooperation with his lab. Dr. Anderson is Distinguished University Professor and Professor of Pathology, Macromolecular Science, and Biomedical Engineering in Case Western University.
Tiger Lifescience took part in MDM East 2015, New York
We took part in the MDM East 2015 in New York City from Jun 13th to 15th. The MDM East is the largest expo of medical design and manufacturing in east coast. We explored the event and found some potential contract manufacturers in the medical industry.